Antiproliferative Agents Alter Vascular Plasminogen Activator Inhibitor-1 Expression: A Potential Prothrombotic Mechanism of Drug-Eluting Stents

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000254677.12861.b8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Coordinated Induction of Plasminogen Activator Inhibitor-1 (PAI-1) and Inhibition of Plasminogen Activator Gene Expression by Hypoxia Promotes Pulmonary Vascular Fibrin Deposition.

Journal of Clinical Investigation
Medicine
1998English

Drug-Eluting Stents

CMAJ
Medicine
2007English

Biochemical Mechanism of Action of a Diketopiperazine Inactivator of Plasminogen Activator Inhibitor-1

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2003English

Drug-Eluting Stents

CMAJ
Medicine
2007English

Plasminogen Activator Inhibitor-1 Controls Vascular Integrity by Regulating VE-Cadherin Trafficking

PLoS ONE
Multidisciplinary
2015English

Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?

PLoS ONE
Multidisciplinary
2010English

Retraction: The Effects of Residual Platelets in Plasma on Plasminogen Activator Inhibitor-1 and Plasminogen Activator Inhibitor-1-Related Assays

PLoS ONE
Multidisciplinary
2018English

Inhibition of Angiogenesisin Vivoby Plasminogen Activator Inhibitor-1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Bioresorbable Vascular Stents and Drug-Eluting Stents in Treatment of Coronary Heart Disease: A Meta-Analysis

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy